SGLT2 Inhibitors May Slow Nonsevere Aortic Stenosis Progression

(MedPage Today) -- For the first time, researchers said SGLT2 inhibitors may have some disease-modifying potential for nonsevere aortic stenosis (AS).
In this retrospective observational study, 4.6% of patients who received SGLT2 inhibitors progressed...